Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Research

Correlation of geopolitics, education, democracy with COVID-19 vaccination rate

verfasst von: Konstantine Chakhunashvili, Davit G. Chakhunashvili, Eka Kvirkvelia, Tornike Toria, Liza Basilaia, Tsira Gorjomeladze

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Introduction

Vaccine hesitancy is an ongoing problem and determining the factors that increase the vaccination rate in various countries of the world might be useful for further implementation of efficient public health policies and negating anti-vaccination campaigns.

Materials and methods

Human Development Index (HDI), Education Index (EI), Democracy Index (DI), COVID-19 vaccination rates, COVID-19 data were collected from public sources such as UNDP - Human Development Reports, UNESCO - Education Index, Economist Intelligence, WHO– COVID-19 Dashboard, Our World In Data, The Financial Times COVID-19 Dashboard. Statistical analysis such as Pearson correlation, and linear regression analyses were done to determine a relation between the above-mentioned indices and COVID-19 vaccination rates (1-dose, 2-dose, booster, and combined).

Results

HDI had the strongest positive correlation with the vaccination rates (1-dose– r (181) = 0.632, p < 0.001, 2-dose– r (181) = 0.671, p < 0.001, booster– r (181) = 0.718, p < 0.001, combined– 0.703, p < 0.001). EI (1-dose– r (177) = 0.560, p < 0.001, 2-dose– r (177) = 0.599, p < 0.001, booster– r (177) = 0.642, p < 0.001, combined– 0.626, p < 0.001), DI (1-dose– r (163) = 0.445, p < 0.001, 2-dose– r (163) = 0.479, p < 0.001, booster– r (163) = 0.534, p < 0.001, combined– 0.508, p < 0.001), as well as Geographic location (1-dose– η (Eta) = 0.610 p < 0.001, 2-dose– η (Eta) = 0.633 p < 0.001, booster– η (Eta) = 0.657, p < 0.001, combined– η (Eta) = 0.645, p < 0.001) had positive correlation with vaccination rates.

Conclusion

There is a strong positive correlation of COVID-19 vaccination rates with HDI and EI.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12889-024-18215-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Vaccines are effective tools in controlling and preventing harmful or deadly infectious diseases, especially in people who are immunocompromised [1]. According to World Health Organization (WHO), between 2010 and 2015, vaccines prevented about 10 million deaths worldwide [1]. Evidence collected throughout the globe suggests that Coronavirus Disease 2019 (COVID-19) vaccines are effective in the reduction of infection rates and prevention of severe illness or death [2]. For the COVID-19 vaccine to achieve the highest efficacy (achieve herd immunity), it is of vital importance that the public vaccination rate is 70% and above [3].
Factors that contribute to the acceptance of vaccination rate may include availability, affordability, effectiveness, and safety of vaccines; or the necessity of vaccination and perception of the disease risk [4]. COVID-19 vaccine hesitancy has been detected in low, middle, and high-income countries globally [5]. According to different data, vaccine refusal in general, including COVID-19 vaccines, is a common phenomenon worldwide and the main reasons for hesitancy involve– a lack of awareness and knowledge, certain religious beliefs, as well a lack of perception of risks or benefits [4]. Cultural, socio-demographic, cognitive, psychological factors, or even political orientations may also lead to vaccine hesitancy [2, 4].
To analyze the real reasons behind the refusal of vaccine acceptance, the epidemiologic triad of host, agent, and environmental factors may be used [4]. Host factors encompass education, income levels, knowledge, or previous experience; The agent factors depend on the perception of susceptibility to the disease, as well as vaccine effectiveness and safety; Environmental factors involve social factors, information spread via media, and public health policy [4]. Distrust of crisis management policy and dissatisfaction with the government policy can influence vaccine hesitancy [5]. On the other hand, strong trust in governments may be a crucial factor for higher rates of vaccine acceptance [6]. Trust in social media or other informal sources of information (friends, family) might negatively affect the vaccination status [7]. Individuals who believe in conspiracy theories, have a high susceptibility to misinformation and are more hesitant to get vaccinated [2]. The conspiracy theories range from COVID-19 being just another flu-like disease to governments reporting fake number of the infected and the dead [8]. In this article we are going to determine which of the factors (geographic location, education, democracy etc.) correlate with the COVID-19 vaccination rate and what is the strength of correlation. This data might be extremely useful for developing novel approaches in public health management.

Materials and methods

This research has a cross-sectional study design and we tried to detect whether democracy index, geographic location, and level of education are correlated with the COVID-19 vaccination rate, separately, all together or in a various combination. Data collection was performed between June, 2023 and August, 2023. Primary data sources included the United Nation Development Programme, The World Health Organization; Secondary sources included Our World in Data and Financial Times COVID-19 dashboard. No exclusion criteria were used for countries or territories. Healthcare logistics and infrastructure were not a subject data analysis in this study, although it might be the major contributing factor throughout in certain geographic locations.

Data collection

We collected the following values: Human Development Index (HDI) [9], Education Index (EI) [10], Democracy Index (DI) [11], COVID-19 vaccination rate (1-dose, 2-dose, booster doses) [1214], COVID-19 death per 1 million (as of November of 2023) [12, 13] [Table 1]. We did not acquire the data from the primary sources, such as local public health authorities, but from secondary trusted sources that acquire and filter the information. The preferred source was the official WHO COVID-19 dashboard, which offers continuous data verification through the official channels to ensure accuracy, reliability, and up-to-date publication of the information. Although, if the data for certain country or territory (for example: Taiwan) was not available through this portal, we utilized Our World in Data or Financial Times COVID-19 dashboards. It should be noted that countries that had vaccination rates more than 100% of the population regarding first or second dose were included with 100%.
Table 1
This data depicts all the data that has been collected and analyzed through this study
Country/
Territory
Human development
Index
Education Index
Democracy index
1-dose
(%)
2-dose
(%)
Booster
(%)
Combined
(%)
Covid-19 death per 1 million population
Afghanistan
0.478
0.415
0.320
29.10
27.30
0.00
56.40
193.61
Albania
0.796
0.745
6.410
47.30
44.77
13.20
105.27
1267.98
Algeria
0.745
0.664
3.660
34.80
17.90
1.30
54.00
153.24
Andorra
0.858
0.714
8.100
76.20
70.20
56.20
202.60
1991.41
Angola
0.586
0.498
3.960
45.30
24.90
4.20
74.40
54
Antigua and Ba
0.788
0.676
 
65.65
63.70
10.50
139.85
1556.97
Argentina
0.842
0.816
6.850
91.20
83.50
72.60
247.30
2866.87
Armenia
0.759
0.749
5.830
38.10
33.30
1.40
72.80
3155.58
Australia
0.951
0.929
8.710
86.60
84.30
76.70
247.60
903.18
Austria
0.916
0.852
8.200
77.30
74.90
67.40
219.60
2520.81
Azerbaijan
0.745
0.709
2.870
53.60
48.20
34.50
136.30
1000.82
The Bahamas
0.812
0.726
7.900
44.30
42.10
9.30
95.70
2058.59
Bahrain
0.875
0.759
2.520
72.90
72.10
46.10
191.10
1043.31
Bangladesh
0.661
0.508
5.990
90.60
76.30
36.80
203.70
172.19
Barbados
0.790
0.777
0.830
57.00
55.50
30.90
143.40
2105.48
Belarus
0.808
0.838
1.990
69.90
66.20
40.00
176.10
746.52
Belgium
0.937
0.893
7.640
80.20
79.30
62.80
222.30
2946.06
Belize
0.683
0.705
-
63.30
55.60
12.80
131.70
1697.57
Bermuda
-
-
-
-
-
-
-
2569.81
Benin
0.525
0.471
4.280
26.50
22.20
0.00
48.70
12.1
Bhutan
0.666
0.445
5.540
90.60
87.80
82.20
260.60
26.84
Bolivia
0.692
0.687
4.510
63.60
53.40
19.80
136.80
1833.02
Bonaire
   
83.48
77.40
38.85
199.73
1515.60
Bosnia and Her
0.780
0.718
5.000
28.80
25.80
3.70
58.30
5062.27
Botswana
0.693
-
-
-
-
-
-
1064.52
Brazil
0.754
0.686
6.780
88.70
82.30
57.70
228.70
3260.90
British Virgin
   
64.88
60.39
12.32
137.59
2042.64
Brunei
0.829
0.704
 
100.00
100.00
77.83
277.83
363.03
Bulgaria
0.795
0.805
6.530
30.40
30.00
11.10
71.50
5675.94
Burkina Faso
0.449
0.286
3.080
20.90
16.00
0.00
36.90
17.55
Burundi
0.426
0.424
2.130
0.20
0.20
0.00
0.40
1.16
Cape Verde
0.662
-
7.650
64.20
55.50
0.10
119.80
701.33
Cambodia
0.593
0.487
3.180
91.10
87.30
62.10
240.50
182.25
Cameroon
0.576
0.547
2.560
12.20
10.30
1.50
24.00
70.72
Canada
0.935
0.899
8.880
91.00
83.30
78.60
252.90
1379.45
Cayman Islands
-
-
-
94.47
92.31
36.62
223.40
538.4
Central Africa
0.576
0.341
1.350
40.60
40.10
4.40
85.10
20.25
Chad
0.394
0.298
1.670
22.80
22.00
0.00
44.80
10.95
Chile
0.855
0.800
8.220
94.60
92.60
82.48
269.68
3159.45
China
0.768
0.644
1.940
93.20
90.90
58.20
242.30
85.47
Colombia
0.752
0.676
6.720
84.30
72.40
28.40
185.10
2751.41
Comoros
0.558
0.473
3.200
50.50
45.70
0.00
96.20
191.25
Democratic Republic of Congo
0.479
0.496
1.480
7.30
6.20
0.00
13.50
14.83
Republic of the Congo
0.571
0.526
2.790
12.60
11.90
0.00
24.50
65.15
Cook Islands
   
86.04
83.85
58.30
228.19
117.43
Costa Rica
0.809
0.719
8.290
89.90
84.10
54.20
228.20
1808.20
Ivory Coast
0.550
0.424
4.220
46.80
39.50
7.70
94.00
29.65
Croatia
0.858
0.791
6.500
57.30
55.50
24.60
137.40
4588.92
Cuba
0.764
0.780
2.650
94.60
88.30
76.50
259.40
760.78
Curaçao
      
0.00
 
Cyprus
0.896
0.808
7.380
75.60
72.80
54.10
202.50
1522.31
Czech Republic
0.889
0.893
7.970
65.20
64.40
48.00
177.60
4099.39
Denmark
0.948
0.920
9.280
82.30
81.70
62.80
226.80
1500.1
Djibouti
0.509
0.309
2.740
32.10
30.10
0.00
62.20
168.62
Dominica
0.720
0.613
 
45.83
42.89
5.55
94.27
1017.07
Dominican Republic
0.767
0.643
6.390
67.30
56.00
23.20
146.50
390.42
Ecuador
0.740
0.697
5.690
86.80
80.60
58.60
226.00
2001.78
Egypt
0.731
0.604
2.930
52.50
39.10
9.60
101.20
223.46
El Salvador
0.675
0.580
5.050
71.70
67.50
35.30
174.50
667.57
Equatorial Guinea
0.596
0.443
1.920
19.30
15.30
0.30
34.90
109.26
Eritrea
0.492
0.281
2.030
-
-
-
-
27.96
Estonia
0.890
0.869
7.960
65.20
63.70
44.20
173.10
2191.45
Eswatini
0.597
-
3.010
42.40
42.30
12.70
97.40
1187.50
Ethiopia
0.498
0.327
3.170
37.50
31.90
2.10
71.50
61.39
Fiji
0.730
0.785
5.550
79.40
71.50
19.00
169.90
951.85
Faroe Islands
-
-
-
85.37
83.69
43.56
212.62
527.14
Finland
0.940
0.905
9.290
81.80
78.60
77.20
237.60
1960.75
France
0.903
0.840
8.070
81.10
78.80
69.00
228.90
2599.32
French Guiana
-
-
-
33.58
30.29
15.51
79.38
1356.02
French Polynesia
-
-
-
67.96
66.55
36.42
170.93
2118.89
Gabon
0.706
0.628
3.400
14.00
11.60
0.10
25.70
128.51
The Gambia
0.500
0.372
4.470
38.70
18.80
1.30
58.80
137.47
Georgia
0.802
0.845
5.200
44.50
34.40
6.70
85.60
4575.38
Germany
0.942
0.940
8.800
77.90
76.30
77.20
231.40
2098.83
Gibraltar
-
-
-
100.00
100.00
124.00
324.00
336.28
Ghana
0.632
0.558
6.430
38.70
28.90
8.20
75.80
43.67
Greece
0.887
0.838
7.970
74.00
71.30
65.40
210.70
3646.52
Greenland
-
-
-
76.62
67.83
0.00
144.45
371.72
Grenada
0.795
0.758
-
39.20
34.69
6.59
80.48
1897.03
Guatemala
0.627
0.514
4.680
52.50
41.70
24.20
118.40
1132.10
Guinea
0.465
0.339
2.320
46.40
25.10
1.70
73.20
33.7
Guinea-Bissau
0.483
0.392
2.560
39.40
21.70
0.05
61.15
84.06
Guyana
0.714
0.596
6.340
62.70
48.30
10.20
121.20
1590.15
Haiti
0.535
0.433
2.810
3.50
2.10
0.00
5.60
74.23
Honduras
0.621
0.502
5.150
65.10
58.10
46.30
169.50
1065.29
Hungary
0.846
0.815
6.640
65.90
63.70
44.20
173.80
4900.82
Iceland
0.959
0.912
9.520
84.50
81.30
69.30
235.10
498.79
India
0.633
0.556
7.040
74.40
68.90
16.10
159.40
376.31
Indonesia
0.705
0.622
6.710
74.40
63.00
24.20
161.60
587.72
Iran
0.774
0.741
1.960
77.50
69.70
37.10
184.30
1656.74
Iraq
0.686
0.534
3.130
28.20
19.70
0.70
48.60
570.27
Republic of Ireland
0.945
0.918
9.130
82.20
81.20
58.60
222.00
1864.58
Israel
0.919
0.874
7.930
72.90
66.80
54.90
194.60
1344.08
Italy
0.895
0.791
7.690
85.40
80.60
77.20
243.20
3167.57
Jamaica
0.709
0.690
7.130
28.50
25.10
1.50
55.10
1269.02
Japan
0.925
0.848
8.330
83.10
81.90
68.44
233.44
602.61
Jordan
0.720
0.711
3.170
47.30
44.70
6.70
98.70
1251.3
Kazakhstan
0.811
0.814
3.080
57.80
56.60
35.40
149.80
983.19
Kenya
0.575
0.551
5.050
26.30
20.00
3.10
49.40
105.3
Kiribati
0.624
0.620
-
-
-
-
-
99.06
South Korea
0.925
0.862
8.030
87.20
86.30
79.80
253.30
693.5
Kuwait
0.831
0.620
3.830
80.90
78.30
34.10
193.30
602.03
Kyrgyzstan
0.692
0.735
3.620
24.80
20.60
3.50
48.90
154.44
Laos
0.607
0.484
1.770
83.70
74.50
27.90
186.10
89.12
Latvia
0.863
0.866
7.370
70.80
68.70
29.00
168.50
4005.07
Lebanon
0.706
0.637
3.640
40.10
35.40
9.70
85.20
1994.08
Lesotho
0.514
0.502
6.190
46.50
43.20
6.30
96.00
307.48
Liberia
0.481
0.434
5.430
75.60
72.60
0.04
148.24
55.44
Libya
0.718
0.616
2.060
33.60
17.90
2.60
54.10
944.9
Liechtenstein
0.935
0.827
-
68.86
68.00
47.25
184.11
2210.65
Lithuania
0.875
0.879
7.310
70.00
67.30
33.80
171.10
3547.38
Luxembourg
0.930
0.792
8.810
76.20
73.20
72.00
221.40
1544.16
Macau
-
-
-
-
-
-
-
-
Madagascar
0.501
0.498
5.700
7.20
6.90
0.40
14.50
48.16
Malawi
0.512
0.451
5.910
20.50
16.20
2.80
39.50
131.63
Malaysia
0.803
0.719
7.300
86.90
85.10
50.30
222.30
1095.84
Maldives
0.747
0.560
 
73.80
71.20
30.90
175.90
603.29
Mali
0.428
0.298
3.230
15.30
12.30
0.00
27.60
32.88
Malta
0.918
0.818
7.700
92.70
91.30
89.30
273.30
1659.50
Marshall Island
0.639
0.723
-
-
-
-
-
408.72
Martinique
-
-
-
40.18
38.78
24.76
103.72
3003.98
Mauritania
0.556
0.389
4.030
44.20
32.10
7.90
84.20
210.51
Mauritius
0.802
0.729
8.140
88.80
86.00
50.50
225.30
811.86
Mayotte
-
-
-
-
-
-
-
573.42
Mexico
0.758
0.678
5.250
76.80
64.10
44.20
185.10
2626.64
Federated States of Micronesia
0.628
0.590
-
72.90
70.34
30.50
173.74
569.29
Moldova
0.767
0.710
6.230
40.40
39.50
14.00
93.90
3713.42
Monaco
-
-
-
69.02
67.96
48.54
185.52
1835.07
Mongolia
0.739
0.766
6.350
69.70
66.60
32.20
168.50
672.09
Montenegro
0.832
0.790
6.450
47.10
45.80
16.30
109.20
4232.30
Montserrat
-
-
-
42.09
39.05
11.26
92.40
1812.83
Morocco
0.683
0.529
5.040
67.80
63.70
18.70
150.20
435.07
Mozambique
0.446
0.385
3.510
59.80
56.80
3.00
119.60
68.25
Myanmar
0.585
0.443
0.740
63.80
50.60
4.10
118.50
359.81
Nauru
-
-
-
100.00
100.00
71.12
271.12
78.8
Namibia
0.615
0.571
6.520
23.60
20.50
4.00
48.10
1597.96
Nepal
0.602
0.502
4.490
94.30
82.20
30.00
206.50
393.85
Netherlands
0.941
0.906
9.000
73.30
68.60
69.20
211.10
1308.7
New Zealand
0.937
0.917
9.610
84.60
81.40
68.40
234.40
679.23
Nicaragua
0.667
0.558
2.500
93.00
89.30
42.60
224.90
35.26
Niger
0.400
0.214
3.730
24.50
21.40
0.00
45.90
12.2
Nigeria
0.535
0.483
3.730
31.00
24.90
3.00
58.90
14.4
North Macedonia
0.770
0.691
6.100
41.00
40.20
7.80
89.00
4756.39
Norway
0.961
0.915
9.810
80.80
75.50
69.60
225.90
1054.78
Oman
0.816
0.706
3.120
63.80
59.70
15.30
138.80
1011.3
Pakistan
0.544
0.411
4.130
63.20
59.90
22.20
145.30
130.00
Palau
0.767
0.844
-
100.00
100.00
71.20
271.20
497.68
Palestine
0.715
0.660
3.860
41.90
37.00
7.00
85.90
1087.22
Panama
0.805
0.692
6.910
81.50
73.30
46.50
201.30
1962.31
Papua New Guinea
0.558
0.430
5.970
4.10
3.40
0.30
7.80
66.06
Paraguay
0.717
0.631
5.890
55.70
49.50
27.80
133.00
2939.20
Peru
0.762
0.689
5.920
91.50
86.10
84.70
262.30
6507.1
Philippines
0.699
0.661
6.730
71.40
67.30
19.20
157.90
577.59
Poland
0.876
0.866
7.040
60.20
59.60
39.90
159.70
3004.55
Portugal
0.866
0.759
7.950
94.80
86.20
68.10
249.10
2697.15
Puerto Rico
-
-
-
100.00
93.97
62.23
256.20
1825.72
Qatar
0.855
0.698
3.650
98.90
98.90
65.90
263.70
256.02
Réunion
-
-
-
-
-
-
-
945.52
Romania
0.821
0.762
6.450
42.40
42.20
9.10
93.70
3488.94
Russia
0.822
0.832
2.280
60.80
54.50
12.80
128.10
2767.46
Rwanda
0.534
0.450
3.100
81.60
71.60
45.40
198.60
106.58
Saint Kitts and Nevis
0.777
0.680
-
63.53
50.76
6.51
120.80
964.75
Collectivity of Saint Martin
-
-
-
-
-
-
-
1445.31
Saint Lucia
0.715
0.676
-
32.75
38.78
5.55
77.08
2279.40
Saint Vincent
0.751
0.655
-
-
-
-
-
1192.78
Samoa
0.707
0.692
-
-
-
-
-
130.4
San Marino
0.853
 
-
76.20
68.59
56.16
200.95
3739.98
São Tomé and Principe
0.618
0.557
-
58.10
47.30
14.90
120.30
351.91
Saudi Arabia
0.875
0.787
2.080
77.40
72.80
45.30
195.50
264.94
Senegal
0.511
0.367
5.720
11.60
8.10
3.70
23.40
113.82
Serbia
0.802
0.778
6.330
49.20
48.10
27.50
124.80
2627.79
Seychelles
0.785
0.727
 
90.10
84.80
45.69
220.59
1605.45
Sierra Leone
0.477
0.390
5.030
48.10
37.90
1.10
87.10
14.53
Singapore
0.939
0.832
6.220
90.70
90.00
78.10
258.80
342.91
Slovakia
0.848
0.832
7.070
52.00
51.10
30.90
134.00
3750.72
Slovenia
0.918
0.886
7.750
60.30
58.20
31.30
149.80
4,475.33
Solomon Island
0.564
0.469
 
50.10
37.00
4.00
91.10
274.76
Somalia
-
-
-
56.45
48.24
0.18
104.87
77.34
South Africa
0.713
0.708
7.050
37.90
33.00
6.50
77.40
1712.95
South Sudan
0.385
0.297
 
19.30
18.90
0.00
38.20
12.64
Spain
0.905
0.824
8.070
87.20
85.90
54.90
228.00
2562.14
Sri Lanka
0.782
0.749
6.470
78.20
67.30
37.50
183.00
773.45
Sudan
0.508
0.328
2.470
24.00
18.90
2.10
45.00
107.65
Suriname
0.730
0.636
6.950
45.70
40.50
8.30
94.50
2271.68
Sweden
0.947
0.904
9.390
75.50
73.70
93.30
242.50
2401.29
Switzerland
0.962
0.897
9.140
70.60
69.60
55.80
196.00
1611.58
Syria
0.577
0.412
1.430
17.40
12.00
0.40
29.80
142.96
Taiwan
-
-
-
92.50
87.40
93.30
273.20
635
Tajikistan
0.685
0.659
1.940
55.40
53.70
51.90
161.00
12.56
Tanzania
0.549
0.441
5.100
48.30
46.00
12.00
106.30
12.92
Thailand
0.800
0.661
6.670
82.20
77.30
46.10
205.60
481.08
East Timor
0.607
0.505
7.060
66.30
59.20
22.50
148.00
102.89
Togo
0.539
0.506
2.990
27.10
17.60
5.20
49.90
32.77
Tonga
0.745
0.770
-
-
-
-
-
112.29
Trinidad and Tobago
0.810
0.722
7.160
53.90
51.30
12.10
117.30
2867.33
Tunisia
0.731
0.659
5.510
61.10
54.10
10.60
125.80
2381.25
Turkey
0.838
0.639
4.350
68.70
63.10
49.10
180.90
1188.39
Turkmenistan
0.745
0.626
1.660
61.80
61.20
55.40
178.40
-
Tuvalu
0.641
-
-
82.90
80.61
48.54
212.05
88.22
Uganda
0.525
0.525
4.550
41.20
28.30
0.90
70.40
76.83
Ukraine
0.773
0.794
5.420
35.70
34.30
1.70
71.70
2768.59
United Arab Emirates
0.911
0.738
2.900
77.40
72.80
45.30
195.50
248.81
United Kingdom
0.929
0.914
8.280
92.90
86.90
69.00
248.80
3438.24
United States
0.921
0.903
7.850
80.76
68.87
35.23
184.86
3384.31
Uruguay
0.809
0.733
8.910
86.50
83.30
82.30
252.10
2236.77
Uzbekistan
0.727
0.718
2.120
62.10
51.20
42.20
155.50
29.34
Vanuatu
0.607
0.529
-
47.20
42.90
5.50
95.60
42.85
Venezuela
0.691
0.741
2.230
77.90
52.60
2.30
132.80
206.91
Vietnam
0.703
0.626
2.730
92.80
87.60
58.90
239.30
440.04
Western Sahara
-
-
-
-
-
-
-
-
Yemen
0.455
0.349
1.950
3.40
2.50
0.20
6.10
64.07
Zambia
0.565
0.580
5.800
59.50
46.50
5.50
111.50
203.27
Zimbabwe
0.593
0.558
2.920
44.10
33.20
8.10
85.40
350.91

Countries and territories

The countries and territories were split into the following geographic groups: North America (NA), South America (SA), Western Europe (WE), Eastern Europe (EE), Asia, Middle East (ME), Africa, and Australia.

Statistical analysis

The statistical analysis was done with SPSS 26 to determine the strength of correlation via Pearson’s correlation and linear regression analysis for scale variables, eta coefficient test for categorical and scale variables, mean, confidence interval (CI)– 95%, p values (< 0.05), etc.

Results

General Information

The worldwide mean for 1-dose, 2-dose, booster dose and combined vaccination rate were, respectively, 60.59% (57.11–64.08, CI– 95%), 55.58% (52.05–59.10, CI– 95%), 30.66% (26.76–34.57, CI– 95%), 146.84% (136.39-157.29, CI– 95%) (Fig. 1).
We also calculated mean HDI, EI and DI for separate geographic locations (Fig. 2) and they were as follows:
HDI for NA– 0.770 (0.664–0.876, CI– 95%), SA– 0.744 (0.712–0.776, CI– 95%), WE– 0.92 (0.911–0.942, CI– 95%), EE– 0.832 (0.811–0.852, CI– 95%), Asia– 0.702 (0.653–0.752, CI– 95%), ME– 0.770 (0.698–0.841, CI– 95%), Africa– 0.559 (0.530–0.589, CI– 95%), Australia– 0.806 (0.540–1.071, CI– 95%).
EI for NA − 0.701 (0.574–0.827, CI– 95%), SA– 0.679 (0.637–0.722, CI– 95%), WE– 0.864 (0.831–0.897, CI– 95%), EE– 0.806 (0.782–0.830, CI– 95%), Asia– 0.620 (0.559–0.680, CI– 95%), ME– 0.657 (0.581–0.734, CI– 95%), Africa– 0.470 (0.434–0.506, CI– 95%), Australia– 0.784 (0.470–1.097, CI– 95%);
DI for NA– 6.64 (5.06–8.22, CI– 95%), SA– 5.56 (4.55–6.57, CI– 95%), WE– 8.64 (8.29-9.00, CI– 95%), EE– 6.24 (5.56–6.91, CI– 95%), Asia– 4.47 (3.48–5.45, CI– 95%), ME– 3.30 (2.45–4.14, CI– 95%), Africa– 4.00 (3.51–4.48, CI– 95%), Australia– 7.73 (4.87–10.59, CI– 95%).
Either weak or very weak correlation was observed between Covid-19 death rate per 1-million population and 1-dose, 2-dose, booster, and combined vaccination rate– r (196) = 0.165, p < 0.001, r (196) = 0.200, p < 0.001, r (196) = 234, p < 0.001, and r(196) = 0.210, p < 0.001, respectively. This leads us to believe that higher death rates, unfortunately, in most of the countries, did not act as a stimuli to get a vaccine shot.

Education Index and COVID-19 vaccination rate

A Pearson correlation coefficient and linear regression analysis were computed to assess the linear relationship between EI and vaccination percentages of 1-dose, 2-dose, booster, as well as combined values (Fig. 3). There was a positive correlation between EI and 1-dose vaccination rate, r (177) = 0.560, r-squared– 0.313, F– 80.66, Beta– 80.19 (62.57–97.82, CI– 95%), p < 0.001, There was a positive correlation between EI and 2-dose vaccination rate, r (177) = 0.599, r-squared– 0.359, F– 99.22, Beta– 86.59 (69.43-103.74, CI– 95%), p < 0.001. There was a positive correlation between EI and booster dose rate, r (177) = 0.642, r-squared– 0.412, F– 123.91, Beta– 100.50 (82.68-118.31, CI– 95%), p < 0.001. There was a positive correlation between EI and combined vaccination rate, r (177) = 0.626, r-squared– 0.392, F– 114.02, Beta– 267.29 (217.89-316.68, CI– 95%), p < 0.001.

Human Development insights and COVID-19 vaccination rate

A Pearson correlation coefficient and linear regression analysis were computed to assess the linear relationship between HDI and vaccination percentages of 1-dose, 2-dose, booster, as well as combined values (Fig. 4). There was a positive correlation between HDI and 1-dose vaccination rate, r (181) = 0.632, r-squared– 0.399, F– 120.10, Beta– 104.37 (85.57-123.16, CI– 95%), p < 0.001. There was a positive correlation between HDI and 2-dose vaccination rate, r (181) = 0.671, r-squared– 0.451, F– 120.10, Beta– 111.76 (93.66-129.86, CI– 95%), p < 0.001. There was a positive correlation between HDI and booster dose rate, r (181) = 0.718, r-squared– 0.516, F– 192.87, Beta– 130.10 (111.61-148.58, CI– 95%), p < 0.001. There was a positive correlation between HDI and combined vaccination rate, r (181) = 0.703, r-squared– 0.494, F– 176.92, Beta– 346.23 (294.87-397.59, CI– 95%), p < 0.001.

Democracy Index and COVID-19 vaccination rate

A Pearson correlation coefficient and linear regression analysis were computed to assess the linear relationship between DI and vaccination percentages of 1-dose, 2-dose, booster, as well as combined values (Fig. 5). There was a positive correlation between DI and 1-dose vaccination rate, r (163) = 0.445, r-squared– 0.198, F– 40.23, Beta– 4.70 (3.23–6.16, CI– 95%), p < 0.001. There was a positive correlation between DI and 2-dose vaccination rate, r (163) = 0.479, r-squared– 0.230, F– 48.62, Beta– 5.09 (3.651–6.53, CI– 95%), p < 0.001. There was a positive correlation between DI and booster dose rate, r (163) = 0.534, r-squared– 0.285, F– 65.12, Beta– 6.18 (4.67–7.69, CI– 95%), p < 0.001. There was a positive correlation between DI and combined vaccination rate, r (163) = 0.508, r-squared– 0.258, F– 56.64, Beta– 15.98 (11.78-20.173, CI– 95%), p < 0.001.

Geographic location and Covid-19 vaccination rate

We tried to determine if there were different results regarding vaccination rate, COVID-19 related death results in various geographic location (Figs. 6 and 7).
The 1-dose vaccination rate mean for NA was 57.11% (41.80-72.42, CI– 95%), SA– 72.79% (65.68–79.91, CI– 95%), WE– 81.31% (77.9-84.73, CI– 95%), EE– 54.73% (48.90-60.55, CI– 95%), Asia– 72.71 (63.84–81.58, CI– 95%), ME– 57.91% (43.01–72.8, CI– 95%), Africa– 39.73 (33.73–45.72, CI– 95%), Australia– 77.00% (66.23–87.76, CI– 95%).
The 2-dose vaccination rate mean for NA was 51.9% (37.97–65.83, CI– 95%), SA– 65.99% (58.72–73.25, CI– 95%), WE– 78.12% (74.59–81.5, CI– 95%), EE– 52.24% (46.4-58.09, CI– 95%), Asia– 67.79% (59.08–76.50, CI– 95%), ME– 53.7% (38.54–68.85, CI– 95%), Africa– 33.04% (27.21–38.86, CI– 95%), Australia– 73.13 (60.61–85.66, CI– 95%).
The booster dose vaccination rate mean for NA was 23.52% (10.42–36.61), SA– 38.15% (27.59–48.71, CI– 95%), WE– 65.45 (56.17–74.74, CI– 95%), EE– 27.40 (19.65–35.16, CI– 95%), Asia– 41.95 (31.62–52.29, CI– 95%), ME– 27.85% (15.18–40.51, CI– 95%), Africa– 6.97% (3.50-10.44, CI– 95%), Australia– 42.68% (25.81–59.55, CI– 95%).
The combined vaccination rate mean for NA was 132.54% (91.80-173.28, CI– 95%), SA– 176.94% (153.38–200.50, CI– 95%), WE– 224.90% (210.63-239.17, CI– 95%), EE– 134.38% (115.51-153.26, CI– 95%), Asia– 182.46% (156.35-208.57, CI– 95%), ME– 139.46% (97.71-181.22, CI– 95%), Africa– 79.75% (65.26–94.23, CI– 95%), Australia– 192.81% (153.65-231.98, CI– 95%).
Eta coefficient was computed to assess the relationship between geographic location and different vaccination rates (vaccination rate was a dependent variable, while the geographic location was independent). 1-dose vaccination rate– η = 0.610 p < 0.001, 2-dose vaccination rate– η = 0.633 p < 0.001, booster dose– η = 0.657, p < 0.001, combined - η = 0.645, p < 0.001.
It caught our attention that Spanish and Portuguese speaking countries had good vaccination results, hence, we grouped Spain, Portugal, and Latin American countries together and ran the analysis. They were close to the WE mean vaccination values and much higher than EE results, whilst the HDI, EI and DI of EE were much closer to WE (Fig. 2). So, we took these countries and compared them to the rest of the world (Fig. 8). In these countries the mean 1-dose, 2-dose, booster, and combined vaccination rate was 78.21% (72.12–84.31, CI– 95%), 70.45% (63.58–77.32, CI– 95%), 43.69% (33.37–54.01, CI– 95%), and 192.3% (170.21-214.52, CI– 95%), respectively.
The highest mean for reported COVID-19 related death per 1-million population was observed in EE– 3388.17 (2861.2-3915.15, CI– 95%) (Table 2; Fig. 7).
Table 2
The table demonstrates mean, minimum, and maximum values of Covid-19 related death rate in different geographic locations of the world
Geographic Region
Mean
Minimum
Maximum
North America
1700.68294
74.230
3384.310
South America
1963.57370
35.260
6507.100
Western Europe
1913.57458
336.280
3739.980
Eastern Europe
3388.17885
746.520
5675.940
Asia
371.38333
12.560
983.190
Middle East
848.36800
64.070
1994.080
Africa
336.20947
1.160
2381.250
Australia
448.47125
42.850
2118.890
Total
1268.12866
1.160
6507.100

Discussion

Out of the indicators HDI has the strongest correlation with the vaccination rate, especially the booster doses; Geographic location, EI and DI coming in with the respective order. WE showed the best results. Therefore, according to the findings of the study, if countries continue to progress and manage to increase HDI and EI locally, the vaccine coverage should go up. As the data suggests these indices are in statistically significant relation with higher vaccination rates throughout the world. However, according to the data, there were certain regions that did have lower vaccination rates in relation to their HDI, EI and DI values. The lower vaccination in the EE resulted in the highest reported COVID-19 death per 1-million population when compared to other regions (Table 2; Fig. 7). Therefore, in the discussion we are going to try and isolate all the possible causes for this disparity and elaborate on them, so that we identify possible areas for further investigation.
For example, if we take a closer look at countries in EE, we should sense that there is some other factor that is contributing to the lower vaccination rate, as it showed higher HDI, EI, however, the vaccination rate was lower than in Asia, SA, Latin American Countries, Portugal, and Spain (Figs. 2, 6 and 7). We tried to collect more information on Portuguese/Spanish speaking countries and Asian countries to identify the circumstances that led to better vaccination results than Eastern European countries despite the latter having higher HDI, EI, indices (Figs. 2, 6 and 7).
The low vaccination rate in most countries of Africa can be attributed to logistical issues, which are caused by military conflicts, lack of finances, low accessibility, lack of energy infrastructure, etc. [15, 16].
In certain countries, such as the Russian Federation we do not even know if their official statistics about the vaccination rate can be trusted since there are a lot of reports about fake COVID-19 vaccine certificates [1719].
The anti-scientific and anti-vaccination campaigns might be the cause for the above, as well as rampant AIDS dissident community, which is built upon the AIDS denialism narratives and they deny the link between HIV and AIDS, promote treatment with natural remedies and lead people to succumb to this terrible disease [2022].
There is a stark disparity between average indices and vaccination rates in some of the countries in Eastern Europe. Even though there is a general correlation between these indices and COVID-19 vaccination rate, still these countries fell short of hitting the average vaccination milestones.
According to a paper Georgia had delayed immunization campaign, insufficient coordination, little evidence-informed policymaking, no effective measures were taken to tackle disinformation (disinformation mainly was spread by far-right groups having ties with Russian federation), and including politically driven management of the pandemic ended in Georgia having one of the worst vaccination rates and one of the highest death rates per 1-million population [Table 1] [23]. Apart from the low vaccine coverage, the latter can also be attributed to bad patient management, which was mainly caused by bad remote management, due to failure of governmental hot-line, and overload of the healthcare system; The hospitalization rate was up to 15.1%– out of 1 660 249 laboratory-confirmed cases, 250 113 patients had been hospitalized, while a private telehealth clinic managed to maintain significantly lower numbers in regards to hospitalization (0.89% during omicron variant domination and 2.48% during delta variant domination) [24].
Eastern Europe is not the only region where the Russian soft power has been noticed. There have been multiple media reports and scientific studies conducted that has exposed anti-vaccination campaigns conducted and backed by The Russian Federation and China; The main purpose of Russian Federation seems to be undermining western science, spreading misinformation about the pandemic and COVID-19, exacerbating tensions among western society; Although, China and Russia have similarities, the main difference is that China stays consistent with a narrative while Russia is revamping the approach through its firehose of falsehoods strategy [25, 26]. Russian State media– Russia Today, which is followed by many on social platforms such as Twitter, YouTube, and Facebook, was working on amplifying tensions regarding vaccine hesitancy and propagating their country as a global humanitarian and scientific leader, especially galvanizing far right and other fringe groups, such as Proud Boys in the United States or neo-Nazis throughout Europe [2628], one such case of online bullying and threatening is believed to have ended in suicide of an Austrian doctor [27]. After Center for European Policy Analysis (CEPA) published the study about the Russian and Chinese disinformation, that was a signal to the western countries to increase their efforts to vigorously tackle the disinformation through social media [29]. There have been numerous reports that social media accounts that had previously been spreading vaccine and COVID-19 disinformation shifted their focus and started to spread Russian narrative about the invasion/war in Ukraine, however, another CEPA report shows that this time around the propaganda was not as successful, because various strategies to deter such disinformation were implemented (such as, disinformation and misinformation policy implementation throughout various social media platforms, flagging and taking down misleading information etc.) [2833]. The information warfare that Russian Federation is waging in the west is not a newly discovered thing and they are engaged not only in undermining medical progress, but electoral campaigns as well [34]; For example, back in 2018 researchers published a paper that studied how Russian Twitter bots and trolls amplified vaccine hesitancy during measles outbreak and, when they did a retrospective review of those accounts, the same trolls and bots were engaged in disseminating divisive topics during 2016 elections, misinformation about 5G wireless technology, in short, they were using everything to create a discord and further polarize the society [34]. All of the above, though, acts as a double-edged sword, since a study from Russia shows that the main reason from vaccine hesitancy are fake news, which creates fear and doubts around the vaccine [33].
Portugal faced a healthcare crisis with overflowing hospitals and soaring COVID-19 deaths, triggering an urgent need to revamp its faltering vaccine program. In response, Vice Adm. Henrique Gouveia e Melo, a former submarine squadron commander, was called upon to lead the charge. Just eight months later, Portugal stands among global vaccination leaders. Portugal’s vaccination success story defied usual challenges. The nation grappled with vaccine misinformation on social media, political divisions, and initial vaccine hesitancy. Admiral Gouveia e Melo, leveraging his military background, instilled a warlike mindset in his team of experts, which comprised military personnel, mathematicians, doctors, and strategists. His key advice for other nations: to select non-political leaders for similar roles. Portugal’s robust national vaccination program, rooted in its experience combating polio, played a pivotal role in its success. The task force, led by Admiral Gouveia e Melo, efficiently designed a system to facilitate mass vaccinations while bolstering public trust by having soldiers and healthcare professionals visibly receive vaccines. Consistency in messaging, emphasizing vaccine safety through diverse personnel, was a crucial element that set Portugal’s vaccination campaign apart from others worldwide [35].
Spain’s decentralization enables customized healthcare solutions, fosters innovation, and enhances responsiveness to regional needs, with the national government playing a facilitating role in coordination rather than imposing centralization. Interestingly, when assessing transparency in COVID-19 health management, Castilla y León, the Basque Country, and the Balearic Islands emerge as the most transparent regions, with rates of 62.5%, 50%, and 50%, respectively. However, it is noteworthy that Asturias, the region with the highest vaccination rates, records a transparency rate of only 40% [36].
According to a study, participants highlighted that belonging to a low-risk group drove vaccine refusal, irrespective of vaccine safety and efficacy. However, higher the risk-group meant higher chance for getting vaccinated [37]. Another crucial factor for vaccine refusal was being religious [37]. Our findings might suggest that since the Pope, Bishops were urging for COVID-19 vaccination in a video message, and were praising scientists for vaccines, calling it an act of love, fostering hope, and stressing the need for widespread availability to end the pandemic, it should have affected the vaccination rates in catholic countries [37, 38].
There are several reasons why COVID-19 vaccination rates were so high in Latin America. One reason is that many Latin American countries have strong public health systems [39, 40]. These public health systems were able to distribute COVID-19 vaccines quickly and efficiently to the population. Another reason is that many Latin Americans have a high level of trust in their governments [41]. This trust was important in ensuring that people were willing to get vaccinated. Finally, many Latin Americans were personally affected by COVID-19. This personal experience made them more likely to get vaccinated [42]. Catholic church being a strong proponent of vaccination must also have been a factor [37, 38].
The most of Asian countries (China, India, Nepal, Thailand etc.) also have higher vaccination rates, relative to their HDI, EI and DI, when compared with EE. Strong public health system, trust of the authorities (highest is China) and cohesive messages from the politicians could have been the reason [4346].
This study, while insightful, possesses certain constraints that warrant careful consideration for a more comprehensive interpretation of its findings. One noteworthy limitation is the omission of critical factors such as the diverse infrastructural landscapes, logistical capabilities, and varied resource availabilities across the countries and territories. The multifaceted nature of these elements can significantly influence the outcomes and may not be adequately captured within the scope of the study. In addition to these contextual limitations, the study’s reliance on a cross-sectional design introduces inherent challenges. The utilization of non-randomized data, and the inherent difficulty in establishing the directionality of variables in cross-sectional studies poses a substantial challenge to drawing causal inferences. Without a temporal sequence of events, discerning whether certain factors precede or succeed others becomes challenging, limiting the study’s ability to establish causation. Considering these limitations, it is crucial for researchers and policymakers alike to interpret the study’s findings with a nuanced understanding of the contextual intricacies and methodological constraints. Addressing these limitations in future research endeavors will not only enhance the robustness of the conclusions but also contribute to the development of more effective and contextually relevant interventions and policies.

Conclusion

In conclusion, the data suggests there is a strong positive correlation of COVID-19 vaccination rates with HDI and EI. Vaccine hesitancy is a complex issue, and it goes beyond just considering HDI and EI. The data indicates that factors influencing vaccination rates are diverse and need comprehensive exploration. Thoroughly studying these additional elements is essential to gaining a deeper understanding of the challenges associated with vaccine hesitancy. This multifaceted issue extends beyond these indices, as indicated by diverse factors influencing vaccination rates, particularly evident in regions like Eastern Europe, where there is a lower vaccination rate relative to HDI and EI values as per the results of the study. A multidimensional and evidence-based approach is essential to achieving higher vaccination rates, ultimately saving lives, and mitigating the impact of the future pandemics.

Acknowledgements

Not applicable.

Declarations

Competing interests

The authors declare no competing interests.
Not applicable.
Not applicable.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Wynter-Adams D, Thomas-Brown P. COVID-19 vaccine hesitancy in a developing country: prevalence, explanatory factors and implications for the future. Public Health. 2023;217:146–54.CrossRefPubMed Wynter-Adams D, Thomas-Brown P. COVID-19 vaccine hesitancy in a developing country: prevalence, explanatory factors and implications for the future. Public Health. 2023;217:146–54.CrossRefPubMed
3.
Zurück zum Zitat Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a Survey of U.S. adults. Ann Intern Med. 2020;173(12):964–73.CrossRefPubMed Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a Survey of U.S. adults. Ann Intern Med. 2020;173(12):964–73.CrossRefPubMed
4.
Zurück zum Zitat Sallam M. COVID-19 Vaccine Hesitancy Worldwide: a concise systematic review of Vaccine Acceptance Rates. Vaccines (Basel). 2021;9(2):160.CrossRefPubMed Sallam M. COVID-19 Vaccine Hesitancy Worldwide: a concise systematic review of Vaccine Acceptance Rates. Vaccines (Basel). 2021;9(2):160.CrossRefPubMed
5.
Zurück zum Zitat Babatope T, Ilyenkova V, Marais D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent. 2023;47(1):45.CrossRefPubMedPubMedCentral Babatope T, Ilyenkova V, Marais D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent. 2023;47(1):45.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.CrossRefPubMed Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.CrossRefPubMed
7.
Zurück zum Zitat Tan M, Straughan PT, Cheong G. Information trust and COVID-19 vaccine hesitancy amongst middle-aged and older adults in Singapore: a latent class analysis Approach. Soc Sci Med. 2022;296:114767.CrossRefPubMedPubMedCentral Tan M, Straughan PT, Cheong G. Information trust and COVID-19 vaccine hesitancy amongst middle-aged and older adults in Singapore: a latent class analysis Approach. Soc Sci Med. 2022;296:114767.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ullah I, Khan KS, Tahir MJ, Ahmed A, Harapan H. Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas. 2021 May-Aug;22(2):93–7. Ullah I, Khan KS, Tahir MJ, Ahmed A, Harapan H. Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas. 2021 May-Aug;22(2):93–7.
9.
Zurück zum Zitat Human Development Insights. UNDP– Human Development Reports, Published in 2022. Human Development Insights. UNDP– Human Development Reports, Published in 2022.
10.
Zurück zum Zitat Education index - United. Nations Educational, Scientific and Cultural Organization (UNESCO). Published in 2018. Education index - United. Nations Educational, Scientific and Cultural Organization (UNESCO). Published in 2018.
11.
Zurück zum Zitat Democracy Index 2022. Economist Intelligence. Published in 2022. Democracy Index 2022. Economist Intelligence. Published in 2022.
13.
Zurück zum Zitat Edouard Mathieu H, Ritchie L, Rodés-Guirao C, Appel C, Giattino J, Hasell B, Macdonald S, Dattani D, Beltekian, Esteban Ortiz-Ospina and Max Roser. (2020) - Coronavirus Pandemic (COVID-19). Published online at OurWorldInData.org. Retrieved from: ‘https://ourworldindata.org/coronavirus’ [Online Resource]. Edouard Mathieu H, Ritchie L, Rodés-Guirao C, Appel C, Giattino J, Hasell B, Macdonald S, Dattani D, Beltekian, Esteban Ortiz-Ospina and Max Roser. (2020) - Coronavirus Pandemic (COVID-19). Published online at OurWorldInData.org. Retrieved from: ‘https://​ourworldindata.​org/​coronavirus’ [Online Resource].
14.
Zurück zum Zitat Covid-19 vaccine. tracker: the global race to vaccinate. The financial Times. published in 2021. Covid-19 vaccine. tracker: the global race to vaccinate. The financial Times. published in 2021.
15.
Zurück zum Zitat Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11(3):427–40.CrossRefPubMedPubMedCentral Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11(3):427–40.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kamara J, Essien U. COVID-19 in Africa: Supply chain disruptions and the role of the Africa Continental Free Trade Agreement. J Glob Health. 2022;12:03085.CrossRefPubMedPubMedCentral Kamara J, Essien U. COVID-19 in Africa: Supply chain disruptions and the role of the Africa Continental Free Trade Agreement. J Glob Health. 2022;12:03085.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Arakpogun EO, Rodrigo P, Olan F. You shall not pass without a jab: an institutional theory perspective to COVID-19 vaccine passport policies. Int J Environ Res Public Health. 2022;19(21):14105.CrossRefPubMedPubMedCentral Arakpogun EO, Rodrigo P, Olan F. You shall not pass without a jab: an institutional theory perspective to COVID-19 vaccine passport policies. Int J Environ Res Public Health. 2022;19(21):14105.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Holt E. Russia considers legislation to tackle rising AIDS denialism. Lancet HIV. 2019;6(7):e423–4.CrossRefPubMed Holt E. Russia considers legislation to tackle rising AIDS denialism. Lancet HIV. 2019;6(7):e423–4.CrossRefPubMed
21.
Zurück zum Zitat Meylakhs P, Rykov Y, Koltsova O, Koltsov S. An AIDS-denialist online community on a Russian social networking service: patterns of interactions with newcomers and rhetorical strategies of persuasion. J Med Internet Res. 2014;16(11):e261.CrossRefPubMedPubMedCentral Meylakhs P, Rykov Y, Koltsova O, Koltsov S. An AIDS-denialist online community on a Russian social networking service: patterns of interactions with newcomers and rhetorical strategies of persuasion. J Med Internet Res. 2014;16(11):e261.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kalichman SC, Eaton L, Cherry C. There is no proof that HIV causes AIDS: AIDS denialism beliefs among people living with HIV/AIDS. J Behav Med. 2010;33(6):432–40.CrossRefPubMedPubMedCentral Kalichman SC, Eaton L, Cherry C. There is no proof that HIV causes AIDS: AIDS denialism beliefs among people living with HIV/AIDS. J Behav Med. 2010;33(6):432–40.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nadareishvili I, Zhulina A, Tskitishvili A. The approach to the COVID-19 pandemic in Georgia—A health policy analysis. Int J Public Health. 2022;67:10.CrossRef Nadareishvili I, Zhulina A, Tskitishvili A. The approach to the COVID-19 pandemic in Georgia—A health policy analysis. Int J Public Health. 2022;67:10.CrossRef
24.
Zurück zum Zitat Chakhunashvili K, Chakhunashvili DG, Kvirkvelia E, et al. Comparative analysis of a private telehealth clinic and country-wide COVID-19 patient management results. Discover Health Syst. 2023;2:22.CrossRef Chakhunashvili K, Chakhunashvili DG, Kvirkvelia E, et al. Comparative analysis of a private telehealth clinic and country-wide COVID-19 patient management results. Discover Health Syst. 2023;2:22.CrossRef
31.
Zurück zum Zitat Ortiz-Sánchez E, Velando-Soriano A, Pradas-Hernández L, Vargas-Román K, Gómez-Urquiza JL. Cañadas-De La Fuente GA, Albendín-García L. Analysis of the Anti-vaccine Movement in Social Networks: a systematic review. Int J Environ Res Public Health. 2020;17(15):5394.CrossRefPubMedPubMedCentral Ortiz-Sánchez E, Velando-Soriano A, Pradas-Hernández L, Vargas-Román K, Gómez-Urquiza JL. Cañadas-De La Fuente GA, Albendín-García L. Analysis of the Anti-vaccine Movement in Social Networks: a systematic review. Int J Environ Res Public Health. 2020;17(15):5394.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Ginossar T, Cruickshank IJ, Zheleva E, Sulskis J, Berger-Wolf T. Cross-platform spread: vaccine-related content, sources, and conspiracy theories in YouTube videos shared in early Twitter COVID-19 conversations. Hum Vaccin Immunother. 2022;18(1):1–13.CrossRefPubMedPubMedCentral Ginossar T, Cruickshank IJ, Zheleva E, Sulskis J, Berger-Wolf T. Cross-platform spread: vaccine-related content, sources, and conspiracy theories in YouTube videos shared in early Twitter COVID-19 conversations. Hum Vaccin Immunother. 2022;18(1):1–13.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Boguslavsky DV, Sharov KS, Sharova NP. Counteracting conspiracy ideas as a measure of increasing propensity for COVID-19 vaccine uptake in Russian society. J Glob Health. 2022;2:03013.CrossRefPubMedPubMedCentral Boguslavsky DV, Sharov KS, Sharova NP. Counteracting conspiracy ideas as a measure of increasing propensity for COVID-19 vaccine uptake in Russian society. J Glob Health. 2022;2:03013.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Broniatowski DA, Jamison AM, Qi S, AlKulaib L, Chen T, Benton A, Quinn SC, Dredze M. Weaponized Health Communication: Twitter Bots and Russian trolls amplify the vaccine debate. Am J Public Health. 2018;108(10):1378–84.CrossRefPubMedPubMedCentral Broniatowski DA, Jamison AM, Qi S, AlKulaib L, Chen T, Benton A, Quinn SC, Dredze M. Weaponized Health Communication: Twitter Bots and Russian trolls amplify the vaccine debate. Am J Public Health. 2018;108(10):1378–84.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Estrela M, Leitão C, Silva TM, Figueiras A, Roque F, Herdeiro MT. Insights on COVID-19 vaccination in Portugal: a qualitative study among Health professionals and teachers. Vaccines (Basel). 2022;10(12):1984.CrossRefPubMed Estrela M, Leitão C, Silva TM, Figueiras A, Roque F, Herdeiro MT. Insights on COVID-19 vaccination in Portugal: a qualitative study among Health professionals and teachers. Vaccines (Basel). 2022;10(12):1984.CrossRefPubMed
36.
Zurück zum Zitat Peña-Ramos JA, Recuero-López F, Sánchez-Bayón A, Sastre FJ. Evaluation of Spanish Health System during the COVID-19 pandemic: accountability and wellbeing results. Int J Environ Res Public Health. 2021;18(24):12907.CrossRefPubMedPubMedCentral Peña-Ramos JA, Recuero-López F, Sánchez-Bayón A, Sastre FJ. Evaluation of Spanish Health System during the COVID-19 pandemic: accountability and wellbeing results. Int J Environ Res Public Health. 2021;18(24):12907.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Han Q, Zheng B, Abakoumkin G, Leander NP, Stroebe W. Why some people do not get vaccinated against COVID-19: Social-cognitive determinants of vaccination behavior. Appl Psychol Health Well Being. 2023;15(3):825–45.CrossRefPubMed Han Q, Zheng B, Abakoumkin G, Leander NP, Stroebe W. Why some people do not get vaccinated against COVID-19: Social-cognitive determinants of vaccination behavior. Appl Psychol Health Well Being. 2023;15(3):825–45.CrossRefPubMed
38.
Zurück zum Zitat Lacsa JEM. COVID-19 vaccination program: the Catholic Church’s all-time support to the government when it is for the common good. J Public Health (Oxf). 2022;44(2):e320–1.CrossRefPubMed Lacsa JEM. COVID-19 vaccination program: the Catholic Church’s all-time support to the government when it is for the common good. J Public Health (Oxf). 2022;44(2):e320–1.CrossRefPubMed
39.
Zurück zum Zitat Castillo C, Villalobos Dintrans P, Maddaleno M. The successful COVID-19 vaccine rollout in Chile: factors and challenges. Vaccine X. 2021;9:100114.CrossRefPubMedPubMedCentral Castillo C, Villalobos Dintrans P, Maddaleno M. The successful COVID-19 vaccine rollout in Chile: factors and challenges. Vaccine X. 2021;9:100114.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat OECD. Primary Health Care for Resilient Health Systems in Latin America, OECD Health Policy studies. Paris: OECD Publishing; 2022. OECD. Primary Health Care for Resilient Health Systems in Latin America, OECD Health Policy studies. Paris: OECD Publishing; 2022.
41.
Zurück zum Zitat Croucher SM, Spencer A, Bustamante S, Nguyen T, Gomez O. COVID-19 and government trust: a spiral of silence analysis in South America. Int Communication Gaz. 2023 May;15:00. Croucher SM, Spencer A, Bustamante S, Nguyen T, Gomez O. COVID-19 and government trust: a spiral of silence analysis in South America. Int Communication Gaz. 2023 May;15:00.
42.
Zurück zum Zitat Keefer P, Scartascini C, Trust. The Key to Social Cohesion and Growth in Latin America and the Caribbean (Executive Summary). IADB. January 2022. Keefer P, Scartascini C, Trust. The Key to Social Cohesion and Growth in Latin America and the Caribbean (Executive Summary). IADB. January 2022.
43.
Zurück zum Zitat Cai Q. Public trust in the Chinese government and life satisfaction during the early stages of the COVID-19 pandemic. Int Rev Admin Sci. 2023 Mar;22:00208523231161297. Cai Q. Public trust in the Chinese government and life satisfaction during the early stages of the COVID-19 pandemic. Int Rev Admin Sci. 2023 Mar;22:00208523231161297.
44.
Zurück zum Zitat Nham E, Song JY, Noh JY, Cheong HJ, Kim WJ. COVID-19 vaccination in Korea: past, Present, and the Way Forward. J Korean Med Sci. 2022;37(47):e351.CrossRefPubMedPubMedCentral Nham E, Song JY, Noh JY, Cheong HJ, Kim WJ. COVID-19 vaccination in Korea: past, Present, and the Way Forward. J Korean Med Sci. 2022;37(47):e351.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Yu S, Yoo EJ, Kim S. The effect of trust in government on elections during the COVID-19 pandemic in South Korea. Asian Politics Policy. 2022;14(2):175–98.CrossRefPubMedCentral Yu S, Yoo EJ, Kim S. The effect of trust in government on elections during the COVID-19 pandemic in South Korea. Asian Politics Policy. 2022;14(2):175–98.CrossRefPubMedCentral
46.
Zurück zum Zitat Kikuchi M, Ishihara S, Kohno M. Correction to: politics of COVID-19 vaccination in Japan: how governing incumbents’ representation affected regional rollout variation. BMC Public Health. 2023;23(1):781.CrossRefPubMedPubMedCentral Kikuchi M, Ishihara S, Kohno M. Correction to: politics of COVID-19 vaccination in Japan: how governing incumbents’ representation affected regional rollout variation. BMC Public Health. 2023;23(1):781.CrossRefPubMedPubMedCentral
Metadaten
Titel
Correlation of geopolitics, education, democracy with COVID-19 vaccination rate
verfasst von
Konstantine Chakhunashvili
Davit G. Chakhunashvili
Eka Kvirkvelia
Tornike Toria
Liza Basilaia
Tsira Gorjomeladze
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18215-4

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe